Conmed (CNMD) Non-Current Deferred Tax Liability (2010 - 2026)

Conmed (CNMD) has reported Non-Current Deferred Tax Liability for 17 consecutive years, with $84.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 21.15% year-over-year to $84.6 million; the trailing twelve-month figure through Jun 2026 stood at $84.6 million (up 21.15% YoY), and the FY2025 full-year result was $79.5 million, down 55.11% from the prior year.
• Non-Current Deferred Tax Liability advanced to $84.6 million in Q2 2026 per CNMD's latest filing, from $81.4 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $177.2 million in Q4 2024 and bottomed at $63.2 million in Q1 2022.
• Historically, Non-Current Deferred Tax Liability has averaged $91.8 million across 5 years, with a median of $72.4 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability jumped 91.0% in 2022, then slumped 55.11% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $170.4 million in 2022, then declined by 0.14% to $170.2 million in 2023, then rose by 4.11% to $177.2 million in 2024, then plunged by 55.11% to $79.5 million in 2025, then gained by 6.35% to $84.6 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $84.6 million, $81.4 million, and $79.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.